Lung Nodule Imaging Biobank for Radiomics and AI Research

NCT04270799 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2021-06-11

No results posted yet for this study

Summary

This study will collect retrospective CT scan images and clinical data from participants with incidental lung nodules seen in hospitals across London. The investigators will research whether machine learning can be used to predict which participants will develop lung cancer, to improve early diagnosis.

Conditions

  • Lung Cancer
  • Pulmonary Nodule, Multiple
  • Pulmonary Nodule, Solitary
  • Lung Neoplasms

Interventions

DIAGNOSTIC_TEST

Machine Learning Classification

Patient's scans will be used as input into in-house software to extract multiple radiomics features. These features will be used to develop a risk-signature which can predict malignancy risk. Patient scans will also be used as input into deep learning/convolutional neural network models to perform automated imaging classification.

Sponsors & Collaborators

  • RM Partners West London Cancer Alliance

    collaborator UNKNOWN
  • Royal Brompton & Harefield NHS Foundation Trust

    collaborator OTHER
  • University College London Hospitals

    collaborator OTHER
  • Imperial College Healthcare NHS Trust

    collaborator OTHER
  • Lewisham and Greenwich NHS Trust

    collaborator OTHER_GOV
  • King's College Hospital NHS Trust

    collaborator OTHER
  • Epsom and St Helier University Hospitals NHS Trust

    collaborator OTHER
  • Institute of Cancer Research, United Kingdom

    collaborator OTHER
  • Guy's and St Thomas' NHS Foundation Trust

    collaborator OTHER
  • UCLH Biomedical Research Centre

    collaborator UNKNOWN
  • Royal Marsden NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Richard Lee, MBBS PhD · The Royal Marsden Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2021-08-31
Completion
2021-08-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04270799 on ClinicalTrials.gov